GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (WBO:COLO) » Definitions » Cyclically Adjusted FCF per Share

Coloplast AS (WBO:COLO) Cyclically Adjusted FCF per Share : €2.27 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Coloplast AS's adjusted free cash flow per share for the three months ended in Mar. 2025 was €0.257. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.27 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Coloplast AS's average Cyclically Adjusted FCF Growth Rate was 6.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Coloplast AS was 9.70% per year. The lowest was 3.30% per year. And the median was 8.30% per year.

As of today (2025-05-23), Coloplast AS's current stock price is €84.36. Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €2.27. Coloplast AS's Cyclically Adjusted Price-to-FCF of today is 37.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 37.57. And the median was 55.56.


Coloplast AS Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted FCF per Share Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 1.97 2.25 2.25 2.16

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.13 2.16 2.24 2.27

Competitive Comparison of Coloplast AS's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted Price-to-FCF falls into.


;
;

Coloplast AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.257/120.2000*120.2000
=0.257

Current CPI (Mar. 2025) = 120.2000.

Coloplast AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.611 100.300 0.732
201509 0.766 100.200 0.919
201512 0.317 99.800 0.382
201603 0.228 100.200 0.274
201606 0.284 100.600 0.339
201609 0.674 100.200 0.809
201612 0.090 100.300 0.108
201703 0.097 101.200 0.115
201706 0.601 101.200 0.714
201709 0.832 101.800 0.982
201712 0.512 101.300 0.608
201803 0.177 101.700 0.209
201806 0.743 102.300 0.873
201809 0.900 102.400 1.056
201812 0.404 102.100 0.476
201903 0.201 102.900 0.235
201906 0.762 102.900 0.890
201909 0.972 102.900 1.135
201912 0.507 102.900 0.592
202003 0.226 103.300 0.263
202006 0.764 103.200 0.890
202009 0.913 103.500 1.060
202012 -0.011 103.400 -0.013
202103 0.327 104.300 0.377
202106 0.729 105.000 0.835
202109 1.052 105.800 1.195
202112 0.586 106.600 0.661
202203 -0.012 109.900 -0.013
202206 0.831 113.600 0.879
202209 1.100 116.400 1.136
202212 0.134 115.900 0.139
202303 0.252 117.300 0.258
202306 0.554 116.400 0.572
202309 0.893 117.400 0.914
202312 0.904 116.700 0.931
202403 -1.692 118.400 -1.718
202406 0.678 118.500 0.688
202409 0.954 118.900 0.964
202412 1.011 118.900 1.022
202503 0.257 120.200 0.257

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Coloplast AS  (WBO:COLO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=84.36/2.27
=37.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 37.57. And the median was 55.56.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Coloplast AS Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines